Organisation paid for research Program year 2025 Source: CMS Open Payments

North Florida Foundation for Research

Neither a doctor nor a teaching hospital

Research payments

$315,984

47 payments

Through program year 2025, North Florida Foundation for Research is reported as receiving $315,984 in research payments, across 47 payments.

By program year

6 rows
Year Kind Amount Payments
2025 Research $10,010 5
2024 Research $28,371 4
2023 Research $73,976 3
2022 Research $93,787 8
2021 Research $54,379 14
2020 Research $55,461 13

Breakdown

Who paid Research payments · program years 2020–2025
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $100,416 3 payments
  2. Roche Products Limited $67,347 8 payments
  3. AbbVie, Inc. $52,565 18 payments
  4. GlaxoSmithKline, LLC. $38,381 9 payments
  5. Kowa Research Institute, Inc. $21,467 4 payments
  6. AstraZeneca Pharmaceuticals LP $15,335 1 payment
  7. Lexicon Pharmaceuticals, Inc. $10,313 1 payment
  8. Novartis Pharmaceuticals Corporation $5,747 2 payments
  9. AstraZeneca UK Limited $4,413 1 payment
Studies the money was for Research payments · program years 2020–2025
  1. CatC inhibitor Phase II in non CF bronchiectasis $63,426 2 payments
  2. M16-100 $44,212 11 payments
  3. A Phase 3, 52-Week, Randomized, Double-Blind, Placebo-Controlled, Para $38,381 9 payments
  4. Trial to Evaluate the Efficacy and Safety of PRM 151 in Patients With Idiopathic Pulmonary Fibrosis $37,257 6 payments
  5. Roll over bronchiectasis $36,990 1 payment
  6. PH III Ole Trial to Evaluate Long Term Safety and Efficacy of PRM 151 in Patients With Ipf $30,090 2 payments
  7. K-877-302 $21,467 4 payments
  8. The CHRONICLE Study is a multi center non interventional prospective cohort study of adults with severe asthma who do not achieve control with high dose inhaled corticosteroid ICS therapy with additional controllers and or require systemic corticosteroid or monoclonal antibody therapy $15,335 1 payment
  9. Efc15156 $10,313 1 payment
  10. Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study $8,353 7 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record